Targeting integrins in drug‐resistant acute myeloid leukaemia

Citations Over TimeTop 10% of 2023 papers

Abstract

Acute myeloid leukaemia (AML) continues to have a poor prognosis, warranting new therapeutic strategies. The bone marrow (BM) microenvironment consists of niches that interact with not only normal haematopoietic stem cells (HSC) but also leukaemia cells like AML. There are many adhesion molecules in the BM microenvironment; therein, integrins have been of central interest. AML cells express integrins that bind to ligands in the microenvironment, enabling adhesion of leukaemia cells in the microenvironment, thereby initiating intracellular signalling pathways that are associated with cell migration, cell proliferation, survival, and drug resistance that has been described to mediate cell adhesion-mediated drug resistance (CAM-DR). Identifying and targeting integrins in AML to interrupt interactions with the microenvironment have been pursued as a strategy to overcome CAM-DR. Here, we focus on the BM microenvironment and review the role of integrins in CAM-DR of AML and discuss integrin-targeting strategies. LINKED ARTICLES: This article is part of a themed issue on Cancer Microenvironment and Pharmacological Interventions. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v181.2/issuetoc.

Related Papers

• → CD200 and membrane protein interactions in the control of myeloid cells(2002)407 cited
• → Soluble Triggering Receptor Expressed on Myeloid Cells-1(2019)31 cited
• → Genital ulcers as diagnostic clue for acute myeloid leukaemia(2018)4 cited
• → Fc receptors on myeloid leukaemic cells: Comparison between assays of rosette-forming cells(1979)3 cited
• → Faculty Opinions recommendation of CAR-T cells targeting a nucleophosmin neoepitope exhibit potent specific activity in mouse models of acute myeloid leukaemia.(2022)